This Project Grant award of $836,355.00 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund a clinical trial to evaluate the impact of Meaning Centered Psychotherapy (MCP) on improving depression, anxiety, and other outcomes for Mexican patients with advanced cancer. The study will be conducted as a collaboration between Memorial Sloan Kettering Cancer Center in New York and the National Mexican Cancer Institute (INCAN) in...
This Project Grant award, identified as R25CA291554, was provided by the National Cancer Institute (NCI), part of the National Institutes of Health, under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award's objective is to test a comprehensive national accelerator program called INCITE (Increasing Caregiver Support Implementation through Training and Education) to train cancer centers and their staff in identifying, implementing, evaluating, and sustaining...
The federal Project Grant award of $716,911 from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), supports the development and evaluation of a digital health intervention called MOSAIC. MOSAIC aims to deliver peer support narratives and psychoeducation to English- and Spanish-speaking stem cell transplant recipients. The award will fund a 2-arm randomized controlled trial to assess MOSAIC's efficacy in reducing psychological distress and improving...
This federal Project Grant award of $1,126,905.00 from the National Cancer Institute (NCI) under the Cancer Centers Support Grants program (CFDA 93.397) supports research on the role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer. The award is held by the University of Southern California (USC) and will be conducted in Los Angeles, CA from August 1, 2024 to July 31, 2026. The funded research aims to advance understanding of cancer biology,...
This Project Grant award of $589,591 from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) supports a study to determine barriers leading to inferior survival for Black and Hispanic patients with Hodgkin lymphoma. The key products/services to be delivered include: Examining differences in the receipt and quality of Hodgkin lymphoma treatment for initial diagnosis and relapse, particularly for patients who have relapsed....
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $956,214 will fund Ceresti Health, Inc. to develop and validate a Spanish-language version of their Caregiver-Enabled Care Program (CECP) for Hispanic/Latino families caring for loved ones with dementia. The CECP is a digital population health intervention that provides personalized education, coaching, and remote monitoring to unpaid/informal caregivers via a dedicated tablet. This project aims...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This $753,446 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) aims to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians in Boston, Hispanic immigrants in Florida, and Hawaiian Natives/Pacific Islanders in Hawaii. The intervention combines education and quality improvement methods using a mechanism called Performance...
This $293,053 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports a 5-year project to refine and pilot test a specialized palliative care intervention (PEACE) for patients with hematologic malignancies receiving adoptive cellular therapy (ACT) and their caregivers. The project aims to 1) refine the PEACE intervention based on findings from an open pilot study, 2) determine the feasibility and acceptability of PEACE through a pilot...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...